Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2793 | 2072 | 37.1 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1835 | 5652 | SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BOMBESIN | Author keyword | 302 | 54% | 19% | 394 |
2 | GASTRIN RELEASING PEPTIDE | Author keyword | 167 | 57% | 10% | 197 |
3 | GASTRIN RELEASING PEPTIDE RECEPTOR | Author keyword | 161 | 85% | 4% | 85 |
4 | NEUROMEDIN B | Author keyword | 160 | 86% | 4% | 81 |
5 | RC 3095 | Author keyword | 76 | 93% | 1% | 28 |
6 | BOMBESIN RECEPTOR SUBTYPE 3 | Author keyword | 55 | 92% | 1% | 22 |
7 | BOMBESIN ANTAGONIST | Author keyword | 50 | 86% | 1% | 25 |
8 | BOMBESIN RECEPTOR | Author keyword | 47 | 88% | 1% | 22 |
9 | BOMBESIN LIKE PEPTIDES | Author keyword | 44 | 85% | 1% | 23 |
10 | BRS 3 | Author keyword | 42 | 94% | 1% | 15 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BOMBESIN | 302 | 54% | 19% | 394 | Search BOMBESIN | Search BOMBESIN |
2 | GASTRIN RELEASING PEPTIDE | 167 | 57% | 10% | 197 | Search GASTRIN+RELEASING+PEPTIDE | Search GASTRIN+RELEASING+PEPTIDE |
3 | GASTRIN RELEASING PEPTIDE RECEPTOR | 161 | 85% | 4% | 85 | Search GASTRIN+RELEASING+PEPTIDE+RECEPTOR | Search GASTRIN+RELEASING+PEPTIDE+RECEPTOR |
4 | NEUROMEDIN B | 160 | 86% | 4% | 81 | Search NEUROMEDIN+B | Search NEUROMEDIN+B |
5 | RC 3095 | 76 | 93% | 1% | 28 | Search RC+3095 | Search RC+3095 |
6 | BOMBESIN RECEPTOR SUBTYPE 3 | 55 | 92% | 1% | 22 | Search BOMBESIN+RECEPTOR+SUBTYPE+3 | Search BOMBESIN+RECEPTOR+SUBTYPE+3 |
7 | BOMBESIN ANTAGONIST | 50 | 86% | 1% | 25 | Search BOMBESIN+ANTAGONIST | Search BOMBESIN+ANTAGONIST |
8 | BOMBESIN RECEPTOR | 47 | 88% | 1% | 22 | Search BOMBESIN+RECEPTOR | Search BOMBESIN+RECEPTOR |
9 | BOMBESIN LIKE PEPTIDES | 44 | 85% | 1% | 23 | Search BOMBESIN+LIKE+PEPTIDES | Search BOMBESIN+LIKE+PEPTIDES |
10 | BRS 3 | 42 | 94% | 1% | 15 | Search BRS+3 | Search BRS+3 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GASTRIN RELEASING PEPTIDE | 196 | 38% | 20% | 413 |
2 | NEUROMEDIN B | 177 | 73% | 6% | 133 |
3 | HUMAN ORPHAN RECEPTOR | 138 | 100% | 2% | 38 |
4 | BOMBESIN LIKE PEPTIDES | 134 | 52% | 9% | 182 |
5 | NEUROMEDIN B RECEPTOR | 99 | 93% | 2% | 38 |
6 | MAMMALIAN BOMBESIN | 98 | 94% | 2% | 34 |
7 | ANTAGONIST RC 3095 | 91 | 81% | 3% | 55 |
8 | RADIOCHEMICAL INVESTIGATIONS | 67 | 85% | 2% | 35 |
9 | BOMBESIN RECEPTOR | 60 | 75% | 2% | 43 |
10 | ALYTESIN | 42 | 94% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
International union of pharmacology. LXVIII. Mammalian bombesin receptors: Nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states | 2008 | 176 | 449 | 80% |
Bombesin Receptor-Mediated Imaging and Cytotoxicity: Review and Current Status | 2011 | 36 | 176 | 72% |
Gastrin-releasing peptide and cancer | 2006 | 83 | 240 | 78% |
Targeting GRPR in urological cancers -from basic research to clinical application | 2013 | 14 | 93 | 72% |
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy | 2007 | 76 | 113 | 81% |
Targeting gastrin releasing peptide receptors New options for the therapy and diagnosis of cancer | 2010 | 20 | 71 | 70% |
Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications | 2004 | 61 | 88 | 82% |
The Role of Bombesin and Bombesin-Related Peptides in the Short-term Control of Food Intake | 2013 | 6 | 209 | 87% |
Radiolabelled peptides for oncological diagnosis | 2012 | 17 | 118 | 49% |
Neuromedin B | 2000 | 52 | 85 | 95% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PEPTIDE S | 13 | 39% | 1.3% | 26 |
2 | CELLULAR MOL NEUROPHARMACOL GRP | 9 | 45% | 0.7% | 15 |
3 | DIGEST DIS BRANCH | 9 | 17% | 2.2% | 46 |
4 | ENDOCRINE POLYPEPTIDE CANC | 5 | 14% | 1.4% | 30 |
5 | UNIV HOSP CPE HCPA | 4 | 28% | 0.5% | 11 |
6 | CELL BIOL EXPT CANC | 3 | 13% | 1.1% | 23 |
7 | CELLULAR SIGNALING PLAST | 3 | 60% | 0.1% | 3 |
8 | DEGENERAT NEUROL DIS | 3 | 11% | 1.1% | 23 |
9 | PRECLIN NEUROPHARMACOL | 2 | 67% | 0.1% | 2 |
10 | PRECLIN NEUROPHARMACOL GRP | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000123889 | NEUROEPITHELIAL BODIES//PULMONARY ENDOCRINE CELLS//NEBS |
2 | 0.0000116698 | SWISS 3T3 CELL//E5050//FREE CALCIUM ION |
3 | 0.0000094426 | ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GHRH ANTAGONIST |
4 | 0.0000081947 | SMALL CELL LUNG CANCER CELL LINE//SMALL CELL LUNG CANCER CELL LINES//DRUG SCREENING ASSAY |
5 | 0.0000066054 | SOMATOSTATIN RECEPTOR SCINTIGRAPHY//PEPTIDE RECEPTOR RADIONUCLIDE THERAPY//OCTREOTATE |
6 | 0.0000065883 | INTRAHYPOTHALAMIC INJECTION//FIXED ACTION PATTERN//NIGROSTRIATAL DOPAMINE |
7 | 0.0000049942 | LHRH RECEPTOR//AN 152//ENDOCRINE POLYPEPTIDE CANC |
8 | 0.0000042718 | ENTEROCHROMAFFIN LIKE CELLS//ECL CELL//ENTEROCHROMAFFIN LIKE CELL |
9 | 0.0000041456 | RX 77368//RAPHE PALLIDUS//GASTRIC CONTRACTILITY |
10 | 0.0000035669 | NEUROENDOCRINE DIFFERENTIATION//SMALL CELL CARCINOMA//RENAL CARCINOID |